IP Library Granted Patent US 10,532,040
Granted Patent B2
US 10,532,040 · App. 14/357,860 · Granted Jan 14, 2020

Methods of treating cancer with herbacetin

Inventors: Ann M. Bode (Minneapolis, MN); Young-Yeon Cho (Minneapolis, MN); Zigang Dong (Minneapolis, MN); Dong Joon Kim (Minneapolis, MN)
Assignee: REGENTS OF THE UNIVERSITY OF MINNESOTA
A61K31/353A61K31/352
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,532,040
App. No.
14/357,860
Granted
Jan 14, 2020
Kind
B2
Abstract

The invention provides methods, uses and compounds for treating cancers. For example, certain embodiments provide a method for treating cancer in a mammal comprising administering to the mammal an effective amount of 3,5,7,8,4′-Pentahydroxyflavone, or a pharmaceutically acceptable salt thereof. Certain other embodiments of the invention provide methods for inactivating ornithine decarboxylase (ODC) in a cell comprising contacting the cell in vitro or in vivo with an effective amount of 3,5,7,8,4′-Pentahydroxyflavone, or a pharmaceutically acceptable salt thereof. The invention also provides a dermal product comprising 3,5,7,8,4′-Pentahydroxyflavone, or a pharmaceutically acceptable salt thereof, wherein the product prophylactically or therapeutically treats sunburn or other sun exposure and/or skin cancer in a mammal.

Claims (9)

1. A method for inactivating ornithine decarboxylase (ODC) in a cell comprising contacting the cell in vitro or in vivo with an effective amount of 3,5,7,8,4′-Pentahydroxyflavone, or a pharmaceutically acceptable salt thereof.

2. A method for inhibiting cancer cell growth comprising contacting the cell in vitro or in vivo with an effective amount of 3,5,7,8,4′-Pentahydroxyflavone, or a pharmaceutically acceptable salt thereof.

3. A method for treating cancer in a mammal comprising administering to the mammal an effective amount of 3,5,7,8,4′-Pentahydroxyflavone, or a pharmaceutically acceptable salt thereof.

4. The method of claim 3 , wherein the mammal is in need of such treatment.

5. The method of claim 3 , wherein the mammal is diagnosed with cancer.

6. The method of claim 3 , wherein the mammal is a human.

7. The method of claim 3 , wherein the cancer is colon cancer or skin cancer.

8. A dermal product comprising 3,5,7,8,4′-Pentahydroxyflavone, or a pharmaceutically acceptable salt thereof, wherein the product prophylactically or therapeutically treats sunburn or other sun exposure and/or skin cancer in a mammal.

9. The product of claim 8 , wherein the product is a sunscreen.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 7, 2015
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035379/0944 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2014
From: BODE, ANN M.; DONG, ZIGANG; KIM, DONG JOON; CHO, YONG-YEON
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 034143/0480 →
Continuity (3)
Provisional Application 61565320 · Nov 30, 2011
Provisional Application 61561436 · Nov 18, 2011
Related Publication 20140303244A1 · Oct 9, 2014